ZYVERSA THERAPEUTICS, INC. Current Assets
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Current Assets of $742.22 thousand as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-05-13
- 2026-03-31: Assets, Current $742.22K.
- 2025-12-31: Assets, Current $463.45K; Assets, Current as first filed $347.90K.
- 2025-09-30: Assets, Current $995.53K.
- 2025-06-30: Assets, Current $549.07K.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-03-31 | $742.22K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $463.45K 10-Q · filed 2026-05-13 | $347.90K 10-K · filed 2026-03-31 |
| 2025-09-30 | $995.53K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $549.07K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.11M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.72M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $390.42K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $641.39K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $2.90M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.35M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.01M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.12M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $2.83M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $6.36M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $438.56K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $566.57K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.06M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.18M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |